NEOGENOMICS INC — Director's Dealing 2018

Jun 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2018-06-01

Reporting Person: JONES STEVEN C (Director, Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-01	Common Stock	A	6897	—	Acquired	241815	Direct
2018-06-01	Common Stock	S	230533	$12.12	Disposed	2750000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-01	Common Stock	$11.6	A	3017	Acquired	2023-06-01	Common Stock (3017.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	190000	Indirect
Common Stock	52157	Indirect
Common Stock	50476	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.27	2022-05-25	Common Stock (10000.0)	10000	Direct
Stock Option (Right to Buy)	$7.15	2021-04-20	Common Stock (100000.0)	100000	Direct
Stock Option (Right to Buy)	$4.78	2020-05-04	Common Stock (225000.0)	225000	Direct

Footnotes

F1: Average price of shares sold.

F2: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.

F3: On May 25, 2017, Mr. Jones was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.

F4: On April 20, 2016, Mr. Jones was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F5: On May 4, 2015, Mr. Jones was granted 225,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.